Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

David R. Holmes(Mayo Clinic in Arizona), Vivek Y. Reddy(Icahn School of Medicine at Mount Sinai), Zoltan G. Turi(Cooper University Hospital), Shephal K. Doshi(St. John's Hospital), Horst Sievert(Cardiovascular Center Frankfurt), Maurice Buchbinder, Christopher M. Mullin(Integra (United States)), Peter Sick(Krankenhaus Barmherzige Brüder)

The Lancet

August 1, 2009

10.1016/s0140-6736(09)61343-x

Cited by 2,214

Abstract

Related Papers

Bayesian Data Analysis

Andrew Gelman, John B. Carlin, Hal S. Stern et al.|Unknown|1995|13.8k

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

Robert G. Hart, Lesly A. Pearce, Maria I. Aguilar|Annals of Internal Medicine|2007|4.8k

A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation

D G Wyse, A.L. Waldo, John Dimarco et al.|New England Journal of Medicine|2002|4.4k

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study

Emelia J. Benjamin|JAMA|1994|2.9k

A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation

Isabelle C. Van Gelder, Vincent E. Hagens, Hans A. Bosker et al.|New England Journal of Medicine|2002|2.4k